Hydrocodone, Benzodiazepines, and Two Prescriptions for People Who Are Not Patients
On a Friday afternoon Dr. Patel extracts tooth #19 for a 34-year-old man whose chart lists no medical history beyond "anxious." Two days later the patient returns with pain rated 9/10, an empty socket with exposed bone, and no swelling. Dr. Patel diagnoses alveolar osteitis and writes hydrocodone/acetaminophen 7.5/325 mg, #24, 1 to 2 tablets every 6 hours as needed, with one refill. While talking, the patient mentions that his primary care physician has him on alprazolam 1 mg three times daily and gabapentin 600 mg three times daily, and asks for "something for anxiety, since I am already on it." Dr. Patel never opened KASPER. Later that afternoon he telephones promethazine with codeine syrup for the patient's wife, whom he has never seen and who has a cough, and writes 20 tablets of oxycodone 5 mg for his brother-in-law's toothache after a 10-minute phone call. The office keeps no prescription log, and none of the three prescriptions is documented in a patient chart.
1. What were Dr. Patel's KASPER obligations before writing the hydrocodone, and what would a query have changed clinically? Explain the reasoning, not just the rule.
Read the worked answer
Framework. Kentucky requires a prescriber to have a KASPER account and to query the system before prescribing a Schedule II controlled substance to a patient for the first time, and at intervals thereafter for continued prescribing. The duty exists to surface other prescribers, overlapping controlled substances, early refills, and multiple-pharmacy patterns that the patient will not volunteer.
Application. Hydrocodone combination products have been Schedule II since October 2014, so this is squarely a first-time Schedule II prescription for this patient. The query was mandatory and was skipped. Clinically, the patient has just disclosed alprazolam 1 mg three times daily and gabapentin 600 mg three times daily. Opioid plus benzodiazepine is the classic combination for fatal respiratory depression and carries an FDA boxed warning; gabapentin adds sedation. A KASPER report would also have revealed whether the alprazolam is being filled as described, whether another prescriber is supplying opioids, and whether the patient is doctor-shopping.
Separately, alveolar osteitis is an inflammatory wound-healing problem, not an infection. The evidence-based first line is irrigation, a medicated dressing, and an NSAID; an opioid is a poor default even setting KASPER aside.
Conclusion. Dr. Patel should have queried KASPER, documented it, considered a non-opioid regimen, and if an opioid was genuinely indicated, prescribed the shortest effective course with a documented risk discussion and no refill. A query was not a clerical step here; it was the safety check the patient's own disclosure made urgent.
2. Analyze the legality and clinical appropriateness of the one refill and of any response to the patient's request for "something for anxiety."
Read the worked answer
Framework. Two independent limits apply: federal prescribing rules and the boundaries of dental practice.
Application.
- The refill. A Schedule II prescription may not be refilled; a refill authorizes a pharmacist to dispense on the original prescription, which is unlawful for Schedule II. If the patient needs more, a new prescription with a new evaluation is required. The quantity also deserves scrutiny: 1 to 2 tablets every 6 hours allows up to 8 tablets daily, so 24 tablets is only a 3-to-6-day supply - appropriate duration, but the refill defeats the point of a short course.
- The anxiety request. Chronic anxiety management is outside the scope of dental practice. Dr. Patel should decline, explain that the alprazolam is his PCP's to manage, and note that a dentist adding a benzodiazepine to a patient already on one, plus an opioid, compounds sedation risk. If in-office anxiolysis is contemplated for a future dental visit, that is a separate sedation-permit question, not a prescription.
- Documentation. None of this appears in a chart. A prescription that is not documented cannot be defended as clinically reasoned.
Conclusion. The refill is unlawful as written and must be removed; the anxiety request should be declined with a documented explanation and a referral back to the primary care physician.
3. Assess the promethazine-codeine and oxycodone prescriptions written for the wife and brother-in-law. What grounds for discipline and what practical risks arise?
Read the worked answer
Framework. A controlled substance prescription is valid only when issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice, in the context of an established practitioner-patient relationship. Kentucky's disciplinary grounds for dentists include prescribing outside the scope of practice, dispensing or prescribing contrary to law, and unprofessional conduct.
Application.
- The wife. She is not a patient; there is no evaluation, no dental diagnosis, and no chart. A cough is a medical complaint. Promethazine with codeine is a controlled substance and, in a child or a patient with respiratory risk, a serious one. Nothing about this is within dentistry.
- The brother-in-law. A 10-minute phone call for a toothache is not an examination. There is no diagnosis, no radiograph, no record, and a Schedule II opioid is being supplied to a person the dentist cannot have evaluated. The family relationship aggravates rather than excuses it, because it suggests the prescription was issued as a favor.
- Collateral risk. Pharmacists have a corresponding responsibility and may refuse or report. If either patient is harmed, the dentist's malpractice coverage and license are both exposed, and the absence of any chart entry makes the defense nearly impossible.
Conclusion. Both prescriptions breach the legitimate-medical-purpose requirement and constitute unprofessional conduct. The corrective steps are to stop, document what happened, decline future requests of this kind, and recognize that a Board complaint is likely to be provable from pharmacy records alone.